What does DR BROECKX WALTER, DERMATOLOGIE do?

DR BROECKX WALTER, DERMATOLOGIE is a specialist medical practice in Mortsel. Private Limited, started on 13 November 2000, 1 establishment.

What is the address of DR BROECKX WALTER, DERMATOLOGIE?

The registered office of DR BROECKX WALTER, DERMATOLOGIE is located at Edegemsestraat 106, 2640 Mortsel.

Is DR BROECKX WALTER, DERMATOLOGIE still active?

Yes. According to the CBE (15 September 2026) DR BROECKX WALTER, DERMATOLOGIE is active, legal situation “Normale toestand”, started on 13 November 2000.

Is DR BROECKX WALTER, DERMATOLOGIE registered on Peppol?

Yes, DR BROECKX WALTER, DERMATOLOGIE is registered on the Peppol network with ID 0208:0473253694.

What is the enterprise number of DR BROECKX WALTER, DERMATOLOGIE?

The enterprise number of DR BROECKX WALTER, DERMATOLOGIE is BE0473253694.

When was DR BROECKX WALTER, DERMATOLOGIE founded?

DR BROECKX WALTER, DERMATOLOGIE was founded on 13 November 2000.

Who are the directors of DR BROECKX WALTER, DERMATOLOGIE?

According to the 2025 annual accounts, the directors of DR BROECKX WALTER, DERMATOLOGIE are: Walter Johan Broeckx.

Is DR BROECKX WALTER, DERMATOLOGIE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 13 November 2000; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR BROECKX WALTER, DERMATOLOGIE make in 2025?

DR BROECKX WALTER, DERMATOLOGIE posted a profit after taxes of € 48,219 in financial year 2025.

What is the revenue of DR BROECKX WALTER, DERMATOLOGIE?

As a small company, DR BROECKX WALTER, DERMATOLOGIE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 85,713.

DR BROECKX WALTER, DERMATOLOGIE (Private Limited)

Dossier DR BROECKX WALTER, DERMATOLOGIE, printed on 15 September 2026 from databakkes.be/en/0473253694/dr-broeckx-walter-dermatologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 26 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

DR BROECKX WALTER, DERMATOLOGIE from Mortsel, company number BE0473253694, closed financial year 2025 with a result of € 48,219 after tax. For that financial year DR BROECKX WALTER, DERMATOLOGIE recorded a gross margin of € 85,713 and equity of € 176,819. Compared with financial year 2024, the result moved from € 51,930 to € 48,219. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 13, 2026.

What it is worth Healthy

€ 176,819

▼ 28% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 48,219

▼ 7% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 33,923

▲ 9% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 115,412 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Wage cost

€ 10,368

▲ 4% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 765

▼ 49% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 6,152

▲ 276% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 105,835 Gross margin 2022: € 105,835 First fiscal year in the series	€ 100,082 Gross margin 2023: € 100,082 ▼ 5% vs 2022 (€ 105,835) Unfavourable step	€ 97,218 Gross margin 2024: € 97,218 ▼ 3% vs 2023 (€ 100,082) Unfavourable step	€ 85,713 Gross margin 2025: € 85,713 ▼ 12% vs 2024 (€ 97,218) Unfavourable step	▼ 12%
Profit after taxes	€ 61,022 Profit after taxes 2022: € 61,022 First fiscal year in the series	€ 57,902 Profit after taxes 2023: € 57,902 ▼ 5% vs 2022 (€ 61,022) Unfavourable step	€ 51,930 Profit after taxes 2024: € 51,930 ▼ 10% vs 2023 (€ 57,902) Unfavourable step	€ 48,219 Profit after taxes 2025: € 48,219 ▼ 7% vs 2024 (€ 51,930) Unfavourable step	▼ 7%
Equity	€ 161,198 Equity 2022: € 161,198 First fiscal year in the series	€ 192,941 Equity 2023: € 192,941 ▲ 20% vs 2022 (€ 161,198) Favourable step	€ 244,012 Equity 2024: € 244,012 ▲ 26% vs 2023 (€ 192,941) Favourable step	€ 176,819 Equity 2025: € 176,819 ▼ 28% vs 2024 (€ 244,012) Unfavourable step	▼ 28%
Total debts	€ 24,630 Total debts 2022: € 24,630 First fiscal year in the series	€ 37,011 Total debts 2023: € 37,011 ▲ 50% vs 2022 (€ 24,630) Unfavourable step	€ 10,588 Total debts 2024: € 10,588 ▼ 71% vs 2023 (€ 37,011) Favourable step	€ 129,126 Total debts 2025: € 129,126 ▲ € 118,538 vs 2024 (€ 10,588) Unfavourable step	▲ € 118,538
Cash	€ 112,511 Cash 2022: € 112,511 First fiscal year in the series	€ 68,533 Cash 2023: € 68,533 ▼ 39% vs 2022 (€ 112,511) Unfavourable step	€ 31,190 Cash 2024: € 31,190 ▼ 54% vs 2023 (€ 68,533) Unfavourable step	€ 33,923 Cash 2025: € 33,923 ▲ 9% vs 2024 (€ 31,190) Favourable step	▲ 9%
Land & buildings	€ 1,441 Land & buildings 2022: € 1,441 First fiscal year in the series	€ 183 Land & buildings 2023: € 183 ▼ 87% vs 2022 (€ 1,441) Unchanged	€ 0 Land & buildings 2024: € 0 ▼ 100% vs 2023 (€ 183) Unchanged	-
Retained profit	€ 142,598 Retained profit 2022: € 142,598 First fiscal year in the series	€ 174,341 Retained profit 2023: € 174,341 ▲ 22% vs 2022 (€ 142,598) Favourable step	€ 225,412 Retained profit 2024: € 225,412 ▲ 29% vs 2023 (€ 174,341) Favourable step	€ 158,219 Retained profit 2025: € 158,219 ▼ 30% vs 2024 (€ 225,412) Unfavourable step	▼ 30%
Dividend	€ 800 Dividend 2022: € 800 First fiscal year in the series	€ 26,159 Dividend 2023: € 26,159 ▲ € 25,359 vs 2022 (€ 800) Unchanged	€ 859 Dividend 2024: € 859 ▼ 97% vs 2023 (€ 26,159) Unchanged	€ 115,412 Dividend 2025: € 115,412 ▲ € 114,553 vs 2024 (€ 859) Unchanged	▲ € 114,553
Balance sheet total	€ 185,828 Balance sheet total 2022: € 185,828 First fiscal year in the series	€ 229,952 Balance sheet total 2023: € 229,952 ▲ 24% vs 2022 (€ 185,828) Unchanged	€ 254,600 Balance sheet total 2024: € 254,600 ▲ 11% vs 2023 (€ 229,952) Unchanged	€ 305,945 Balance sheet total 2025: € 305,945 ▲ 20% vs 2024 (€ 254,600) Unchanged	▲ 20%

Key figures of DR BROECKX WALTER, DERMATOLOGIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR BROECKX WALTER, DERMATOLOGIE?

What happened at DR BROECKX WALTER, DERMATOLOGIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 13, 2026 New annual accounts for financial year 2025: profit of € 48,219 (▼ 7% vs 2024). filed late Source: NBB ↗
Jan 1, 2001 New establishment in Mortsel. KBO
Nov 13, 2000 Start of the company according to the CBE. KBO
2000 Walter Johan Broeckx became a director. NBB

In short

From € 61,022 profit in 2022 to € 48,219 profit in 2025.

Paid € 107,296 in corporate taxes since 2022.

Best year ever: 2022, with € 61,022 profit.

Paid out € 143,230 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR BROECKX WALTER, DERMATOLOGIE? We notify you, reason included.

Follow DR BROECKX WALTER, DERMATOLOGIE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Walter Johan Broeckx

DR BROECKX WALTER, DERMATOLOGIE

Behind DR BROECKX WALTER, DERMATOLOGIE is Walter Johan Broeckx.

See the full network in the app

Directors

According to the 2025 annual accounts

Walter Johan Broeckx

Director

since 2000

Establishments

Establishment units

Physical locations of this company

Registered office

Edegemsestraat 106

2640 Mortsel

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0473.253.694
VAT number: BE 0473.253.694
Registered office: Edegemsestraat 106, 2640 Mortsel
Names & denominations: DR BROECKX WALTER, DERMATOLOGIE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 13 November 2000
Peppol: Active · Active since 27 Nov 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗